Pharvaris N.V. (PHVS)
Healthcare • Biotechnology
StockNasdaqGSSwitzerlandNL00150005Y4
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Pharvaris N.V., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 20:55. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Aug 2026 06:00 | -0.65 | -0.70 | -7.1% | Miss |
| 02 Apr 2026 06:00 | -0.62 | -0.71 | -15.4% | Miss |
| 12 Nov 2025 08:00 | -0.67 | -0.60 | +10.7% | Beat |
| 12 Aug 2025 16:00 | -0.77 | -0.83 | -8.5% | Miss |
| 13 May 2025 16:00 | -0.83 | -0.85 | -2.8% | Miss |
| 07 Apr 2025 06:00 | -0.73 | -0.64 | +11.9% | Beat |
| 13 Nov 2024 16:00 | -0.60 | -0.77 | -27.4% | Miss |
| 14 Aug 2024 06:00 | -0.58 | -0.55 | +4.8% | Beat |
| 08 May 2024 16:00 | -0.57 | -0.52 | +8.8% | Beat |
| 10 Apr 2024 16:00 | -0.54 | -0.76 | -40.8% | Miss |
| 02 Nov 2023 06:00 | -0.59 | -0.58 | +2.4% | Beat |
| 07 Aug 2023 06:00 | -0.58 | -0.63 | -7.8% | Miss |
| 08 May 2023 06:00 | -0.76 | -0.67 | +12.0% | Beat |
| 05 Apr 2023 06:00 | -0.65 | -1.16 | -78.5% | Miss |
| 08 Dec 2022 06:00 | -0.63 | -0.25 | +60.6% | Beat |
| 12 Sep 2022 06:00 | -0.56 | -0.38 | +32.1% | Beat |
| 11 May 2022 08:00 | -0.46 | -0.48 | -3.6% | Miss |
| 29 Mar 2022 08:00 | -0.83 | -0.09 | +89.1% | Beat |
| 10 Nov 2021 08:00 | -0.47 | -0.39 | +17.6% | Beat |
| 30 Jul 2021 08:00 | -0.46 | -0.94 | -104.4% | Miss |
| 26 May 2021 09:00 | -0.35 | -0.66 | -90.4% | Miss |
| 29 Apr 2021 16:00 | -1.14 | -2.18 | -90.7% | Miss |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -175.7M | — | -2.97 | -19.8% | -137.2M |
| 2024 | 0 | — | -134.2M | — | -2.48 | +5.7% | -120.7M |
| 2023 | 0 | — | -100.9M | — | -2.63 | -15.9% | -93.1M |
| 2022 | 0 | — | -76.3M | — | -2.27 | — | -67.3M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 33.59 | 34.54 | 33.00 | 33.90 | -0.82% | 284,046 | |
| 11 Nov 2026 | 34.01 | 34.72 | 33.81 | 34.18 | +0.56% | 421,700 | |
| 10 Nov 2026 | 34.10 | 35.05 | 33.21 | 33.99 | -1.39% | 745,400 | |
| 09 Nov 2026 | 34.80 | 35.47 | 34.05 | 34.47 | +0.23% | 638,300 | |
| 06 Nov 2026 | 32.85 | 35.21 | 32.28 | 34.39 | +5.72% | 405,100 | |
| 05 Nov 2026 | 34.33 | 34.66 | 32.53 | 32.53 | -5.24% | 932,800 | |
| 04 Nov 2026 | 35.06 | 35.42 | 33.03 | 34.33 | -1.29% | 309,400 | |
| 03 Nov 2026 | 33.90 | 35.30 | 33.90 | 34.78 | +3.73% | 577,200 | |
| 02 Nov 2026 | 33.68 | 34.21 | 32.90 | 33.53 | 0.00% | 633,000 | |
| 30 Oct 2026 | 33.48 | 33.94 | 33.05 | 33.53 | -0.15% | 1,481,200 | |
| 1,245 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Pharvaris Presents Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting (opens in a new tab) 12 Nov 2026 15:28
- Pharvaris Reports Third Quarter 2026 Financial Results and Provides Business Update (opens in a new tab) 12 Nov 2026 11:50
- Pharvaris Q3 EPS $(0.77) Beats $(0.82) Estimate (opens in a new tab) Benzinga · 12 Nov 2026 07:52
- Pharvaris (PHVS) Stock Could Look Pricey Following Phase 3 Momentum (opens in a new tab) Simply Wall St. · 04 Nov 2026 15:11
- Bank of America backs Pharvaris on breakthrough for rare swelling disease (opens in a new tab) TheStreet · 26 Oct 2026 23:00
- BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble? (opens in a new tab) Insider Monkey · 15 Oct 2026 19:05
- Could Real-World HAE Oral Preference Data Be a Pivotal Signal for Pharvaris' (PHVS) Strategy? (opens in a new tab) Simply Wall St. · 08 Oct 2026 16:10
- What Does Pharvaris (PHVS) Phase 3 HAE Success Mean Now? (opens in a new tab) Simply Wall St. · 19 Sep 2026 16:12
- PHVS Stock Rises 10% in a Month: What Is Driving the Rally? (opens in a new tab) Zacks · 15 Sep 2026 14:50
- Pharvaris (PHVS) Reports an 83% HAE Attack-Rate Reduction. Can Oral Convenience Win? (opens in a new tab) Insider Monkey · 11 Sep 2026 00:25
- BCRX Stock Heads For Fifth Straight Day In The Red – RBC Capital Says BioCryst Faces A ‘Challenging Near-Term Outlook’ (opens in a new tab) Stocktwits · 10 Sep 2026 16:52
- Pharvaris Could Gain Hereditary Angioedema Market Share on Deucrictibant XR Data, RBC Says (opens in a new tab) MT Newswires · 09 Sep 2026 16:18
- Pharvaris charts approval course for swelling disorder drug on Phase III win (opens in a new tab) Clinical Trials Arena · 09 Sep 2026 12:33
- BCRX Stock Posts Worst Day In Over 6 Months After PHVS Trial Win In Rare Swelling Disease (opens in a new tab) Stocktwits · 09 Sep 2026 00:24
- Biotech Stocks, With 'Blowout' And 'Bull Case' Results, Rocket To Record Highs (opens in a new tab) Investor's Business Daily · 08 Sep 2026 21:24
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 34.18 USD
- Market cap
- 2.3B
- Exchange
- NasdaqGS
- Country
- Switzerland
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow PHVS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.